Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Oral care products specifically for GLP-1 dry mouth The market for dry mouth products has expanded significantly as GLP-1 medications have become more popular
GLP-1 drugs like Ozempic can curb addiction risk, study finds There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction
Retatrutide achieved 24% loss in 48 weeks while semaglutide achieved 17% in 68 weeks and tirzepatide achieved 22% in 72 weeks
The FDA has issued public communications addressing concerns associated with compounded semaglutide and tirzepatide products, including risks involving dosing errors, storage handling, adverse events, and misleading marketing claims
GLP-1 receptor agonists mimic this hormone to produce therapeutic effects
Daniel Skovronsky, Eli Lillys chief scientific officer and president of Lilly Research Labs
US$ 23.60
US$ 29.14
US$ 25.68
